Related Experiment Video
Updated: Feb 17, 2026

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
[Clostridium difficile Infection: Epidemiology, Clinical Presentation, Therapy and Prevention]
Magnus Kaffarnik1, Caroline Isner2, Uwe Hamsen3
1Chirurgische Klinik, Charité - Universitätsmedizin Berlin, Deutschland.
Clostridium difficile infections (CDI) are a significant cause of hospital-acquired diarrhea. Early diagnosis, prompt treatment, and infection control measures are crucial for managing CDI and preventing severe outcomes.
Area of Science:
- Infectious Diseases
- Gastroenterology
- Hospital Epidemiology
Background:
- Clostridium difficile infections (CDI) are a frequent cause of hospital-acquired diarrhea in both medical and surgical patients.
- Clinical manifestations vary widely, from mild diarrhea to severe conditions like pseudomembranous enterocolitis and toxic megacolon.
- Recurrent CDI poses a significant challenge due to high complication and mortality rates, necessitating early diagnosis and intervention.
Purpose of the Study:
- To review the clinical presentation, risk factors, and management strategies for Clostridium difficile infections.
- To highlight the importance of early diagnosis and therapeutic interventions to mitigate complications and mortality.
- To emphasize the critical role of infection prevention and control measures in hospital settings.
Main Methods:
- Review of current literature on Clostridium difficile infections.
- Analysis of clinical presentations, diagnostic approaches, and therapeutic options.
- Examination of preventive strategies and antibiotic stewardship.
Main Results:
- CDI presents a spectrum of illness, with recurrent infections being common.
- Standard therapy involves antibiotics, with monoclonal antibodies and vaccination under development.
- Surgical intervention and fecal microbiota transplantation are options for severe or recurrent cases.
Conclusions:
- Prompt diagnosis and initiation of therapy are essential for reducing CDI complications and mortality.
- A multi-faceted approach including infection control, antibiotic stewardship, and novel therapies is required.
- Preventive measures are vital to curb the in-hospital transmission of Clostridium difficile.
Related Concept Videos
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

